Skip to main content
Have a personal or library account? Click to login
Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line Cover

Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line

Acta Pharmaceutica
Volume 63 (2013): Issue 4 (December 2013)
By: ,  ,  ,   and    
Open Access
|Dec 2013
Authors

Authors

Tiam Feridooni

Chris Mac Donald

Di Shao

Pollen Yeung

Remigius U. Agu

Remigius.agu@dal.ca

DOI: https://doi.org/10.2478/acph-2013-0038 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 493 - 503
Published on: Dec 31, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
rat myoblast (H9c2),
cytoprotection,
dexrazoxane,
doxorubicin,
diltiazem,
irinotecan
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Tiam Feridooni, Chris Mac Donald, Di Shao, Pollen Yeung, Remigius U. Agu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 63 (2013): Issue 4 (December 2013)
Previous article
Next article